119 related articles for article (PubMed ID: 16790486)
1. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Bhuller Y; Wells PG
Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
[TBL] [Abstract][Full Text] [Related]
2. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
3. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress.
Abramov JP; Wells PG
Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional characterization of zebrafish ATM.
Imamura S; Kishi S
Int J Biochem Cell Biol; 2005 May; 37(5):1105-16. PubMed ID: 15743681
[TBL] [Abstract][Full Text] [Related]
5. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
6. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
7. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
Abramov JP; Wells PG
FASEB J; 2011 Jul; 25(7):2188-200. PubMed ID: 21478259
[TBL] [Abstract][Full Text] [Related]
8. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation.
Hishiya A; Ito M; Aburatani H; Motoyama N; Ikeda K; Watanabe K
Bone; 2005 Oct; 37(4):497-503. PubMed ID: 16027059
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
[TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
[TBL] [Abstract][Full Text] [Related]
12. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
Kasapinovic S; McCallum GP; Wiley MJ; Wells PG
Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029
[TBL] [Abstract][Full Text] [Related]
13. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
14. Effect of ATM heterozygosity on heritable DNA damage in mice following paternal F0 germline irradiation.
Baulch JE; Li MW; Raabe OG
Mutat Res; 2007 Mar; 616(1-2):34-45. PubMed ID: 17161850
[TBL] [Abstract][Full Text] [Related]
15. The role of ATM in breast cancer development.
Prokopcova J; Kleibl Z; Banwell CM; Pohlreich P
Breast Cancer Res Treat; 2007 Aug; 104(2):121-8. PubMed ID: 17061036
[TBL] [Abstract][Full Text] [Related]
16. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Wells PG; Bhuller Y; Chen CS; Jeng W; Kasapinovic S; Kennedy JC; Kim PM; Laposa RR; McCallum GP; Nicol CJ; Parman T; Wiley MJ; Wong AW
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):354-66. PubMed ID: 16081118
[TBL] [Abstract][Full Text] [Related]
17. Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits.
Wells PG; McCallum GP; Lam KC; Henderson JT; Ondovcik SL
Birth Defects Res C Embryo Today; 2010 Jun; 90(2):103-9. PubMed ID: 20544694
[TBL] [Abstract][Full Text] [Related]
18. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
19. Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice.
Erker L; Schubert R; Elchuri S; Huang TT; Tarin D; Mueller K; Zielen S; Epstein CJ; Wynshaw-Boris A
Free Radic Biol Med; 2006 Aug; 41(4):590-600. PubMed ID: 16863992
[TBL] [Abstract][Full Text] [Related]
20. Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.
Winrow CJ; Pankratz DG; Vibat CR; Bowen TJ; Callahan MA; Warren AJ; Hilbush BS; Wynshaw-Boris A; Hasel KW; Weaver Z; Lockhart DJ; Barlow C
Hum Mol Genet; 2005 Sep; 14(18):2671-84. PubMed ID: 16087685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
